Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology...

Oct 25, 2023

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

Press releases are necessarily short, so we like to go...

Oct 25, 2023

More news

All Article Blog Pressrelease

Sifted: Using E.coli to reshape the $6tn chemicals industry

Feb 11, 2021

Article

Forbes: New McKinsey Report Sees A $4 Trillion Gold Rush In This One Hot Sector

May 30, 2020

Article

DI Digital (Swe): Investerare pekar ut ny trend – ger nya läkemedel och bränslen

May 06, 2020

Article

Forbes: The Future Of Manufacturing Is Built With Biology.

Apr 23, 2020

Article

1 2

Media contact

Karim Engelmark Cassimjee

CEO and co-founder

press@enginzyme.com

Media kit

Download images
Download presskit

Contacts

Stay up to date with our latest news

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

More news

Sifted: Using E.coli to reshape the $6tn chemicals industry

Forbes: New McKinsey Report Sees A $4 Trillion Gold Rush In This One Hot Sector

DI Digital (Swe): Investerare pekar ut ny trend – ger nya läkemedel och bränslen

Forbes: The Future Of Manufacturing Is Built With Biology.

Media contact

Karim Engelmark Cassimjee

Media kit

About

Products and services

Contact

Contacts

Stay up to date with our latest news

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

More news

Sifted: Using E.coli to reshape the $6tn chemicals industry

Forbes: New McKinsey Report Sees A $4 Trillion Gold Rush In This One Hot Sector

DI Digital (Swe): Investerare pekar ut ny trend – ger nya läkemedel och bränslen

Forbes: The Future Of Manufacturing Is Built With Biology.

Media contact

Karim Engelmark Cassimjee

Media kit

Stay in touch with us. Sign up here for EnginZyme Insights.

Thanks for signing up!

Could not submit form.

Stay in touch with us.
Sign up here for EnginZyme Insights.